CVE-2023-40153
Last modified
CVE-2023-40153 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software. . EPSS estimates a 0.30% chance of exploitation in the next 30 days.
Description
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Dexma | Dexgate | 20130114 |
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-40153?
How severe is CVE-2023-40153?
How do I fix CVE-2023-40153?
Are you affected by CVE-2023-40153?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
